{"Symbol": "LLY", "AssetType": "Common Stock", "Name": "Eli Lilly and Company", "Description": "Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.", "CIK": "59478", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "PHARMACEUTICAL PREPARATIONS", "Address": "LILLY CORPORATE CTR, DROP CODE 1112, INDIANAPOLIS, IN, US", "OfficialSite": "https://www.lilly.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "734572970000", "EBITDA": "19268301000", "PERatio": "70.04", "PEGRatio": "1.192", "BookValue": "15.81", "DividendPerShare": "5.2", "DividendYield": "0.0071", "EPS": "11.68", "RevenuePerShareTTM": "50.01", "ProfitMargin": "0.235", "OperatingMarginTTM": "0.428", "ReturnOnAssetsTTM": "0.153", "ReturnOnEquityTTM": "0.843", "RevenueTTM": "45042700000", "GrossProfitTTM": "36624400000", "DilutedEPSTTM": "11.68", "QuarterlyEarningsGrowthYOY": "1.018", "QuarterlyRevenueGrowthYOY": "0.447", "AnalystTargetPrice": "1009.93", "AnalystRatingStrongBuy": "7", "AnalystRatingBuy": "16", "AnalystRatingHold": "4", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "1", "TrailingPE": "70.04", "ForwardPE": "35.71", "PriceToSalesRatioTTM": "16.5", "PriceToBookRatio": "51.76", "EVToRevenue": "16.98", "EVToEBITDA": "50.22", "Beta": "0.504", "52WeekHigh": "969.25", "52WeekLow": "677.09", "50DayMovingAverage": "835.66", "200DayMovingAverage": "847.18", "SharesOutstanding": "897989000", "DividendDate": "2025-03-10", "ExDividendDate": "2025-02-14"}